RAG1
V(D)J recombination-activating protein 1
Also known as: MGC43321, RAG1_HUMAN, RNF74
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15918
- Gene
- RAG1
- Ensembl
- ENSG00000166349
- Chromosome
- 11
- Canonical length
- 1043 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is involved in activation of immunoglobulin V-D-J recombination. The encoded protein is involved in recognition of the DNA substrate, but stable binding and cleavage activity also requires RAG2. Defects in this gene can be the cause of several diseases. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1043 residues, UniProt reviewed canonical sequence.
>P15918|RAG1
1 MAASFPPTLG LSSAPDEIQH PHIKFSEWKF KLFRVRSFEK TPEEAQKEKK DSFEGKPSLE
61 QSPAVLDKAD GQKPVPTQPL LKAHPKFSKK FHDNEKARGK AIHQANLRHL CRICGNSFRA
121 DEHNRRYPVH GPVDGKTLGL LRKKEKRATS WPDLIAKVFR IDVKADVDSI HPTEFCHNCW
181 SIMHRKFSSA PCEVYFPRNV TMEWHPHTPS CDICNTARRG LKRKSLQPNL QLSKKLKTVL
241 DQARQARQHK RRAQARISSK DVMKKIANCS KIHLSTKLLA VDFPEHFVKS ISCQICEHIL
301 ADPVETNCKH VFCRVCILRC LKVMGSYCPS CRYPCFPTDL ESPVKSFLSV LNSLMVKCPA
361 KECNEEVSLE KYNHHISSHK ESKEIFVHIN KGGRPRQHLL SLTRRAQKHR LRELKLQVKA
421 FADKEEGGDV KSVCMTLFLL ALRARNEHRQ ADELEAIMQG KGSGLQPAVC LAIRVNTFLS
481 CSQYHKMYRT VKAITGRQIF QPLHALRNAE KVLLPGYHHF EWQPPLKNVS SSTDVGIIDG
541 LSGLSSSVDD YPVDTIAKRF RYDSALVSAL MDMEEDILEG MRSQDLDDYL NGPFTVVVKE
601 SCDGMGDVSE KHGSGPVVPE KAVRFSFTIM KITIAHSSQN VKVFEEAKPN SELCCKPLCL
661 MLADESDHET LTAILSPLIA EREAMKSSEL MLELGGILRT FKFIFRGTGY DEKLVREVEG
721 LEASGSVYIC TLCDATRLEA SQNLVFHSIT RSHAENLERY EVWRSNPYHE SVEELRDRVK
781 GVSAKPFIET VPSIDALHCD IGNAAEFYKI FQLEIGEVYK NPNASKEERK RWQATLDKHL
841 RKKMNLKPIM RMNGNFARKL MTKETVDAVC ELIPSEERHE ALRELMDLYL KMKPVWRSSC
901 PAKECPESLC QYSFNSQRFA ELLSTKFKYR YEGKITNYFH KTLAHVPEII ERDGSIGAWA
961 SEGNESGNKL FRRFRKMNAR QSKCYEMEDV LKHHWLYTSK YLQKFMNAHN ALKTSGFTMN
1021 PQASLGDPLG IEDSLESQDS MEFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 368 nTPM
Expression across tissuesHPA
Tissue
- thymus: 368 nTPM
- bone marrow: 4.1 nTPM
- spleen: 2.6 nTPM
- thyroid gland: 2.3 nTPM
- kidney: 1.3 nTPM
- small intestine: 1 nTPM
Single-cell type
- salivary ionocytes: 38 nCPM
- sertoli cells: 11 nCPM
- loop of henle epithelial cells: 8.2 nCPM
- choroid plexus epithelial cells: 7.6 nCPM
- renal connecting tubule cells: 6.9 nCPM
- lymphatic endothelial cells: 6.7 nCPM
Immune cell
- MAIT T-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 0.7 nTPM
- choroid plexus: 0.7 nTPM
- midbrain: 0.7 nTPM
- hypothalamus: 0.6 nTPM
- medulla oblongata: 0.6 nTPM
- pons: 0.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RAG1.
Disease | AllUniProt
Conditions RAG1 is implicated in, by any mechanism.
- Combined cellular and humoral immune defects with granulomas (CHIDG) MIM:233650
- Severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-negative/NK-cell-positive (T(-)B(-)NK(+) SCID) MIM:601457
- Omenn syndrome (OS) MIM:603554
- Alpha/beta T-cell lymphopenia, with gamma/delta T-cell expansion, severe cytomegalovirus infection and autoimmunity (T-CMVA) MIM:609889
Disease | GeneticClinVar
173 pathogenic / likely-pathogenic of 949 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive
- Combined immunodeficiency with skin granulomas
- Combined immunodeficiency due to partial RAG1 deficiency
- Histiocytic medullary reticulosis
- Severe combined immunodeficiency disease
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.58
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- B cell differentiation
- chromatin organization
- DNA recombination
- immune response
- negative regulation of thymocyte apoptotic process
- positive regulation of T cell differentiation
- pre-B cell allelic exclusion
- protein autoubiquitination
- regulation of behavioral fear response
- T cell differentiation in thymus
- T cell homeostasis
- thymus development
- V(D)J recombination
- visual learning
Molecular functions
- DNA binding
- endonuclease activity
- histone binding
- hydrolase activity
- metal ion binding
- protein homodimerization activity
- sequence-specific DNA binding
- ubiquitin protein ligase activity
- ubiquitin-protein transferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger, RING-type
- Zinc finger, RING/FYVE/PHD-type
- Zinc finger, RING-type, conserved site
- Zinc finger, C3HC4 RING-type
- Zinc finger C2H2 superfamily
- Zinc finger, C3HC4 type (RING finger)
- V(D)J recombination-activating protein 1, Zinc finger
- RAG nonamer-binding domain
- V(D)J recombination-activating protein 1
- RAG1 importin-binding
- V(D)J recombination-activating protein 1, DNA-binding domain
- V(D)J recombination-activating protein 1, pre-RNase H domain
- V(D)J recombination-activating protein 1, RNase H domain
- V(D)J recombination-activating protein 1, ZnC2 domain
- V(D)J recombination-activating protein 1, ZnH2 domain
- V(D)J recombination-activating protein 1, C-terminal domain
- V(D)J recombination-activating protein 1, RING finger, HC subclass
- Recombination-activating protein 1 zinc-finger domain
- RAG1 importin binding
- Recombination-activation protein 1 (RAG1) nonamer-binding domain
- Recombination-activation protein 1 (RAG1) DNA-binding domain
- Recombination-activation protein 1 (RAG1) pre-RNase H domain
- Recombination-activation protein 1 (RAG1) RNase H domain
- Recombination-activation protein 1 (RAG1) ZnC2 domain
- Recombination-activation protein 1 (RAG1) ZnH2 domain
- Recombination-activation protein 1 (RAG1) C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RAG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAG1 as an antibody target. Whether an autoantibody or antibody against RAG1 could matter depends on whether native RAG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RAG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...